Integrated Proteins Intrinsic Value
Integrated Proteins (INTEGFD) median intrinsic value is ₹52.00 from 6 valuation models (range ₹40–₹63), vs current price ₹133.95 — -61.2% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse INTEGFD annual financials for revenue, profit, balance sheet and cash flow data.
INTEGFD Valuation Methods Summary — DCF, Graham Number & P/E
Integrated Proteins intrinsic value across 6 models vs current price ₹133.95 — upside/downside and value range per method. Also explore Integrated Proteins stock price data download to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹42.00 | ₹33.60 - ₹50.40 | -68.6% | EPS: ₹3.50, Sector P/E: 12x |
| Book Value Method | asset | ₹50.00 | ₹45.00 - ₹55.00 | -62.7% | Book Value/Share: ₹50.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹52.00 | ₹46.80 - ₹57.20 | -61.2% | Revenue/Share: ₹65.00, P/S: 0.8x |
| PEG Ratio Method | growth | ₹56.00 | ₹50.40 - ₹61.60 | -58.2% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹40.18 | ₹36.16 - ₹44.20 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| Graham Defensive Method | conservative | ₹62.75 | ₹56.48 - ₹69.03 | -53.2% | EPS: ₹3.50, BVPS: ₹50.00 |
INTEGFD Intrinsic Value vs Market Price — All Valuation Models
Integrated Proteins fair value range ₹40–₹63 vs current market price ₹133.95 across 6 valuation models. For current market price and key ratios, visit Integrated Proteins stock price NSE.
INTEGFD Intrinsic Value Analysis — Undervalued or Overvalued?
Integrated Proteins median intrinsic value ₹52.00, current price ₹133.95 — Trading Above Calculated Value by 61.2%, margin of safety -100.0%.
What is the intrinsic value of INTEGFD?
Based on our comprehensive analysis using 6 different valuation methods, the estimated intrinsic value of Integrated Proteins (INTEGFD) is ₹52.00 (median value). With the current market price of ₹133.95, this represents a -61.2% variance from our estimated fair value.
The valuation range spans from ₹40.18 to ₹62.75, indicating ₹40.18 - ₹62.75.
Is INTEGFD undervalued or overvalued?
Based on our multi-method analysis, Integrated Proteins (INTEGFD) appears to be trading above calculated value by approximately 61.2%.
INTEGFD Financial Health — Key Ratios vs Industry Benchmarks
Integrated Proteins financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | 1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.81x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
INTEGFD Cash Flow Quality — Operating & Free Cash Flow
Integrated Proteins operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-24 Cr | ₹-24 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |